Abstract
Background
Pretreatment evaluation of axillary lymph nodes (ALNs) and marking of biopsied nodes in patients with newly diagnosed breast cancer is becoming routine practice. We sought to test tattooing of biopsied ALNs with a sterile black carbon suspension (Spot™). The intraoperative success of identifying tattooed ALNs and their concordance to sentinel nodes was determined.
Methods
Women with suspicious ALNs and newly diagnosed breast cancer underwent palpation and/or ultrasound-guided fine needle aspiration or core needle biopsy, followed by injection of 0.1 to 0.5 ml of Spot™ ink into the cortex of ALNs and adjacent soft tissue. Group I underwent surgery first, and group II underwent neoadjuvant therapy followed by surgery. Identification of black pigment and concordance between sentinel and tattooed nodes was evaluated.
Results
Twenty-eight patients were tattooed, 16 in group I and 12 in group II. Seventeen cases had evidence of atypia or metastases, 8 (50 %) in group I and 9 (75 %) in group II. Average number of days from tattooing to surgery was 22.9 (group I) and 130 (group II). Black tattoo ink was visualized intraoperatively in all cases, except one case with microscopic black pigment only. Fourteen group I and 10 group II patients had black pigment on histological examination of ALNs. Sentinel nodes corresponded to tattooed nodes in all except one group I patient with a tattooed non-sentinel node.
Conclusion
Tattooed nodes are visible intraoperatively, even months later. This approach obviates the need for additional localization procedures during axillary staging.
Similar content being viewed by others
References
Boughey JC, Suman VJ, Mittendorf EA, et. al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer. The ACOSOG Z1071 (Alliance) Clinical Trial. JAMA. 2013;310:1455–61.
Caudle AS, Cupp JA, Kuerer HM. Management of axillary disease. Surg Oncol Clin N Am. 2014;23:473–86.
Morrow M, Dang CT. Sentinel node biopsy after neoadjuvant chemotherapy, a new standard for patients with axillary metastases? JAMA. 2013;310(14):1449–50.
Bryant JA, Siddiqi NJ, Loveday EJ, Irvine GH. Presurgical, ultrasound-guided anchor-wire marking of impalpable cervical lymph nodes. J Laryngol Otol. 2005;119(8):627–8.
Straver ME, Loo CE. Alderliesten T, Rutgers EJT, Vrancken Peeters MTFD. Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer. Br J Surg. 2010;97:1226–31.
Donker MD, Straver ME, Wesseling J, Loo CE, Schot M, Drukker CA, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg. Epub 16 Apr 2014.
Shatz BA, Weinstock LB, Swanson PE, Thyssen EP. Long-term safety of India ink tattoos in the colon. Gastrointest Endosc. 1997;45:153–6.
Askin MP, Waye JD, Fiedler L, Harpaz N. Tattoo of colonic neoplasms in 113 patients with a new sterile carbon compound. Gastrointest Endosc. 2002;56:339–42.
Mainiero MB. Regional lymph node staging in breast cancer: the increasing role of imaging and ultrasound-guided axillary lymph node fine needle aspiration. Radiol Clin N Am. 2010;48:989–97.
Yamashita M, Hovanessian-Larsen L, Sener SF. The role of axillary ultrasound in the detection of metastases from primary breast cancers. Am J Surg. 2013;205:242–4.
Lee, B, Lim AK, Krell J, Satchithananda K, Coombes RC, Lewis JS, et al. The efficacy of axillary ultrasound in the detection of nodal metastasis in breast cancer. J Am J Roentgenol. 2013;200:W314–20.
Rautiainen S, Masarwah A, Sudah M, Sutela A, Pelkonen O, Joukainen S, et al. Axillary lymph node biopsy in newly diagnosed invasive breast cancer: comparative accuracy of fine-needle aspiration biopsy versus core-needle biopsy. Radiology. 2013;269:54–60.
van Rijk MC, Nieweg OE, Rutgers EJ, Oldenburg HS, Olmos RV, Hoefnagel CA, et al. Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection. Ann Surg Oncol. 2006;13:475–9.
Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer: a multicenter validation Study. N Engl J Med. 1998;339(14):941–6.
Alvarez S, Añorbe E, Alcorta P, López F, Alonso I, Cortés J. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. Am J Roentgenol. 2006;186:1342–8.
Ibrahim-Zada I, Grant CS, Glazebrook KN, Boughey JC. Preoperative axillary ultrasound in breast cancer: safely avoiding frozen section of sentinel lymph nodes in breast-conserving surgery. J Am Coll Surg. 2013;217:7–15.
Holwitt DM, Swatske ME, Gillanders WE, Monsees BS, Gao F, Aft RL, et al. The combination of axillary ultrasound and ultrasound-guided biopsy in an accurate predictor of axillary stage in clinically node-negative breast cancer patients. Am J Surg. 2008;196:477–82.
Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis. JAMA. 2011;305(6):569–75.
Rouzier R, Extra JM, Klijanienko J, et. al. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol. 2002;20:1304–10.
Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg. 1999;230:72–8.
Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384(9938):164–72.
Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14:609–18.
Boughey JC, Suman VJ, Mittendorf EA, et al. The role of sentinel lymph node surgery in patients with node positive breast cancer (T0–T4, N1-2) who receive neoadjuvant chemotherapy: results from the ACOSOG Z1017 trial [abstract no. S2-1]. Presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium; 4–8 Dec 2012; San Antonio.
Gradishar W, Anderson BO, Blair S et al. Breast cancer version 3.2014. J Natl Compr Netw. 2014;12:542–90.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Choy, N., Lipson, J., Porter, C. et al. Initial Results with Preoperative Tattooing of Biopsied Axillary Lymph Nodes and Correlation to Sentinel Lymph Nodes in Breast Cancer Patients. Ann Surg Oncol 22, 377–382 (2015). https://doi.org/10.1245/s10434-014-4034-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-014-4034-6